合资转控股 金矿商OrdRiver拟全购Dampier
ACB News《澳华财经在线》报道:Ord River资源公司(ASX:ORD)29日向金矿项目合资方Dampier金业(ASX:DAU)发起场外要约,拟收购其全部股份。Dampier建议股东在董事会作出正式回应前,不要采取任何行动。
Ord拟以6份Ord股份及1.5分现金换购1份Dampier股份,隐含要约价每股0.0486澳元较Dampier三月加权平均价溢出78.7%。要约期限截至6月5日,可能延期。Ord表示,接受要约后Dampier股东将可加入一家股票流动性较高,优质资产集中、融资能力更强的公司。
Dampier称不久会就要约作出正式推荐意见,股东将有充分时间考虑相关条件。
ACB News《澳华财经在线》资料库显示,ORD为一家资源开发企业,2005年3月在澳交所上市。主要资产包括Suplejack金矿项目(100%),SARCO铝土矿项目(40%,与中国有色金属有限公司合资)。
Ord River于去年12月介入Dampier的Plutonic Dome项目开发,并将其定性为重要金矿资产,计划在未来2年内出资600万,以最终获得该项目70%权益。
目前初级勘探商面临筹资困境,很难在不稀释股东权益的情况下吸引投资。Dampier金业董事会主席曾表示,引进Ord River作为合资方符合股东最大利益,可在保证短期融资的同时,推进项目开发。
尽管大部分业内人士认可合资交易的合理性,Dampier大股东Columbus并不支持该协议。今年初Columbus一度要求改组董事会,增加代表席位,撤除当时的执行董事,试图“抢占”控制权(详情)。
在目的未能完全达到后,再次提议改换董事人选。管理层动荡情况下,本次收购的前景显得非常模糊。
相关阅读

-
Strong China Demand Fuels Compumedics (ASX: CMP) Neuro-Imaging Growth New A$4.9m MEG Order from Beijing Normal University Lifts Total Orders to A$25m
ASX-listed medical technology company Compumedics Limited (ASX: CMP) announced on November 10 that it has secured a new A$4.9 million magnetoencephalography (MEG) system order from Beijing Normal University, lifting total contracted MEG revenues to about A$25 million. The deal strengthens the company’s leadership in Asia’s fast-growing neuro-imaging market and highlights robust demand from China’s expanding neuroscience sector.

-
IMARC Exclusive | Barton Gold CEO Alexander Scanlon: In the Age of De-Dollarisation, Gold Is Re-Shaping the Global Value Order
This interview was conducted by ACB News (澳华财经在线) as part of its exclusive IMARC 2025 coverage in Sydney. ACB News is an award-winning bilingual financial media platform established in Australia in 2012. Over the past thirteen years, it has become a trusted source of professional financial and securities market news, serving high-net-worth Chinese investors across Australia and the broader Asia-Pacific region.
-
美国最大外卖平台发布首款送餐机器人 进军智能硬件领域
当地时间周二,美国最大外卖平台DoorDash宣布推出送餐机器人与餐厅智能秤,正式对外展示其多年积累的硬件研发成果。DoorDash联合创始人Stanley Tang介绍了这款名为 “Dot” 的四轮自动驾驶机器人。

-
Australian Stock Market Hits Record High in Wednesday Morning Trade – ASX 200 Index Touches 8,639 Points Amid Broad-Based Market Momentum
In an exclusive report published on Monday titled “[U.S. Market Watch] Wall Street Rises at Start of June, Dow Could Head Towards 45,000 – Further Signals Needed to Confirm Trend”, we noted that despite a late-week pullback, the overall trend of the Australian equity market remained upward.

-
福特一季度营收超预期,Ford Blue表现强劲
福特汽车2024年一季度财报显示,调整后每股盈利0.14美元,超预期亏损。Ford Blue部门营收210亿美元,超出分析师预期的200.8亿美元,公司预计将面临15亿美元关税影响,暂停2025年业绩预测。

-
ImpediMed (ASX: IPD) Reports Record Q3 Performance; Commercial Momentum Builds and Shares Rebound
5 May 2025 | ACB News – Sydney,ImpediMed Limited (ASX: IPD), a leading Australian medical technology company, has reported record results for the third quarter of FY2025, ended 31 March. Key financial metrics reached new highs as the company continues to scale deployment of its SOZO® digital health platform in the U.S.

-
ImpediMed (ASX: IPD) Delivers Record Q3 Results; Shares Rebound Last Week with Increasing Trading Volume
ImpediMed Limited (ASX: IPD) has reported record financial results for Q3 FY25, with revenue reaching A$3.4 million (+28% YoY), cash receipts at A$4.1 million, and ARR rising to A$13.7 million (+27% YoY). Total Contracted Value (TCV) hit A$4.9 million, up 53% from the previous quarter.
-
欧洲私人股本集团殷拓(EQT)正谈判收购爱尔兰视频游戏服务公司Keywords Studios
据英国金融时报报道,欧洲私人股本集团殷拓(EQT)正在就以22亿英镑收购爱尔兰视频游戏服务公司Keywords Studios展开深入谈判,这是对在伦...
免责声明:本网站信息仅供一般参考,不构成投资或财务建议。虽力求准确与完整,但不保证信息的准确性、完整性或时效性。投资有风险,决策前请咨询专业独立顾问。使用本网站即视为接受本免责声明。
热门点击
-
- 【1.20】今日财经时讯及重要市场资讯
-
- 美欧关税新变量叠加高位行情 全球股市面临阶段性再定价
-
- 【1.19】今日财经时讯及重要市场资讯
-
- 美国加征关税,欧盟拟反制——跨大西洋博弈观察
-
- 逆势增长考虑分红! Yancoal兖煤澳大利亚(ASX:YAL))四季度产销双旺 现金余额突破21亿澳元
-
- 【异动股】中国新生儿数据发布后 奶粉股The a2 Milk Company (ASX:A2M)盘中暴跌逾14%
-
- 【异动股】中国新生儿数据发布后 奶粉股The a2 Milk Company (ASX:A2M)盘中暴跌逾14%
-
- 【1.21】今日财经时讯及重要市场资讯
-
- 中澳铁矿石谈判进行时:必和必拓力拓罕见联手开采西澳铁矿石
-
- 国防股飙升势头或持续数年 全球紧张局势和美国军备政策推动新一波投资热潮
-
- 新州公共部门高级行政人员数量两年下降逾8% 财政纪律措施初显成效
-
- Theta Gold Mines(ASX:TGM)董事局主席Bill Guy新年寄语:迈向生产阶段的关键一年 (更新)
-
- TELIX Pharmaceuticals (ASX:TLX) 前列腺癌成像剂新药申请获中国药品监管机构受理
-
- 【异动股】预制模块化数据中心公司DXN(ASX:DXN) 飙涨18%:携战略伙伴布局印尼数字基础设施市场
-
- 心系天下||鹧鸪天·观人民币汇率有感|张三铁

